title: Mitochondrial biogenesis during skeletal muscle regeneration.
abstract: Myogenesis requires energy production for the execution of a number of regulatory and biosynthesis events. We hypothesized that mitochondrial biogenesis would be stimulated during skeletal muscle regeneration. Tibialis anterior muscles of male Sprague-Dawley rats were injected with 0.75% bupivacaine and removed at 3, 5, 7, 10, 14, 21, or 35 days after injection (n = 5-7/group). Two main periods emerged from the histochemical analyses of muscle sections and the expression of proliferating cell nuclear antigen, desmin, and creatine phosphokinase: 1) activation/proliferation of satellite cells (days 3-14) and 2) differentiation into muscle fibers (days 5-35). The onset of muscle differentiation was accompanied by a marked stimulation of mitochondrial biogenesis, as indicated by a nearly fivefold increase in citrate synthase activity and state 3 rate of respiration between days 5 and 10. Peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) mRNA level and mitochondrial transcription factor A (mtTFA) protein level peaked on day 10 concurrently with the state 3 rate of respiration. Therefore, transcriptional activation by PGC-1 and mtTFA may be one of the mechanisms regulating mitochondrial biogenesis in regenerating skeletal muscle. Taken together, our results suggest that mitochondrial biogenesis may be an important regulatory event during muscle regeneration.
authors.affiliation: Laboratoire de Physiologie, Groupe Physiologie et Physiopathologie de l'Exercice et du Handicap Groupement d'Intérêt Public-E2S, Faculté de Médecine, 42023 Saint-Etienne, France.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Duguez
authors.forename: Léonard
authors.initials: L
authors.lastname: Féasson
authors.forename: Christian
authors.initials: C
authors.lastname: Denis
authors.forename: Damien
authors.initials: D
authors.lastname: Freyssenet
mesh_terms: D000818:Animals; D001835:Body Weight; D002045:Bupivacaine / Q000494:pharmacology; D002454:Cell Differentiation; D002455:Cell Division; D002950:Citrate (si)-Synthase / Q000378:metabolism; D003402:Creatine Kinase / Q000032:analysis; D004268:DNA-Binding Proteins; D003893:Desmin / Q000032:analysis; D006651:Histocytochemistry; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000502:physiology*; D024101:Mitochondrial Proteins; D009124:Muscle Proteins / Q000032:analysis; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure*; D009336:Necrosis; D009687:Nuclear Proteins / Q000032:analysis; D009929:Organ Size; D010101:Oxygen Consumption; D025221:Phosphofructokinases / Q000378:metabolism; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012038:Regeneration; D014157:Transcription Factors / Q000032:analysis / Q000235:genetics
chemical_list: D004268:DNA-Binding Proteins; D003893:Desmin; D024101:Mitochondrial Proteins; D009124:Muscle Proteins; D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen; D012333:RNA, Messenger; C489030:Tfam protein, rat; D014157:Transcription Factors; C422562:mitochondrial transcription factor A; C111264:peroxisome-proliferator-activated receptor-gamma coactivator-1; D007770:L-Lactate Dehydrogenase; D002950:Citrate (si)-Synthase; D025221:Phosphofructokinases; D003402:Creatine Kinase; D002045:Bupivacaine